Similar articles

• Immunoblot detection of P-glycoprotein in human tumors and cell lines.

  Fredericks WJ, Chen YF, Baker RM. Fredericks WJ, et al. Cancer Treat Res. 1991;57:121-49. doi: 10.1007/978-1-4615-3872-1_6. Cancer Treat Res. 1991. PMID: 1686713 Review. No abstract available.
• How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein.

  Broxterman HJ, Lankelma J, Pinedo HM. Broxterman HJ, et al. Eur J Cancer. 1996 Jun;32A(6):1024-33. doi: 10.1016/0959-8049(96)00045-7. Eur J Cancer. 1996. PMID: 8763344 Review. No abstract available.
• Can nuclear medicine predict response to chemotherapy?

  Moretti JL, Caglar M, Duran-Cordobes M, Morere JF. Moretti JL, et al. Eur J Nucl Med. 1995 Feb;22(2):97-100. doi: 10.1007/BF00838937. Eur J Nucl Med. 1995. PMID: 7758509 No abstract available.
• Detection of low-level expression of P-glycoprotein in ACHN renal adenocarcinoma cells.

  Kawamoto S, Deguchi T, Nezasa S, Yamada S, Okano M, Kawada Y. Kawamoto S, et al. Jpn J Cancer Res. 1996 May;87(5):475-9. doi: 10.1111/j.1349-7006.1996.tb00248.x. Jpn J Cancer Res. 1996. PMID: 8641984 Free PMC article.
• Role of gene amplification in drug resistance.

  Schoenlein PV. Schoenlein PV. Cancer Treat Res. 1994;73:167-200. doi: 10.1007/978-1-4615-2632-2_9. Cancer Treat Res. 1994. PMID: 7710905 Review. No abstract available.